Significance of Serum Ribavirin Concentration in Combination Therapy of Interferon and Ribavirin for Chronic Hepatitis C

Publisher： Karger

E-ISSN： 1423-0100|48|2-3|138-144

ISSN： 0300-5526

Source： Intervirology, Vol.48, Iss.2-3, 2005-03, pp. : 138-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

Combined Interferon and Ribavirin Therapy for Chronic Hepatitis C in Taiwan

By  

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 91-95

Karger

Access to resources Recommend Favorite

Long-term Re-treatment with Interferon and Ribavirin Combination Therapy in Patients with Chronic Hepatitis C who are Non-responders to Interferon Alone: a Preliminary Study

By Vega P.   Castro A.   Hermida M.   López Calvo S.   Pedreira J.  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 4, 1999-09 ,pp. : 359-361

Informa Healthcare

Access to resources Recommend Favorite

Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin

By  

Intervirology, Vol. 50, Iss. 6, 2008-02 ,pp. : 439-446

Karger

Access to resources Recommend Favorite